FNY Investment Advisers’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,800	Closed	-$49K	–	653
2023 Q4	$49K	Buy	+8,800	New	+$49K	0.05%	184